Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 2 | 472 | 7q21.11 | CD36 | CD36 molecule (CD36 blood group) | |
Mouse | 2 | 472 | 5 8.11 cM | Cd36 | CD36 molecule | |
Rat | 2 | 472 | 4q11 | Cd36 | CD36 molecule |
Previous and Unofficial Names ![]() |
CD36 molecule | collagen type I receptor, thrombospondin receptor | platelet glycoprotein 4 | SCARB3 | fatty acid translocase (FAT) |
Database Links ![]() |
|
Alphafold | P16671 (Hs), Q08857 (Mm) |
ChEMBL Target | CHEMBL1744526 (Hs), CHEMBL2176845 (Mm) |
Ensembl Gene | ENSG00000135218 (Hs), ENSMUSG00000002944 (Mm), ENSRNOG00000005906 (Rn) |
Entrez Gene | 948 (Hs), 12491 (Mm), 29184 (Rn) |
Human Protein Atlas | ENSG00000135218 (Hs) |
KEGG Gene | hsa:948 (Hs), mmu:12491 (Mm), rno:29184 (Rn) |
OMIM | 173510 (Hs) |
Pharos | P16671 (Hs) |
RefSeq Nucleotide | NM_000072 (Hs), NM_001159558 (Mm), NM_031561 (Rn) |
RefSeq Protein | NP_000063 (Hs), NP_001153030 (Mm), NP_113749 (Rn) |
UniProtKB | P16671 (Hs), Q08857 (Mm) |
Wikipedia | CD36 (Hs) |
Download all structure-activity data for this target as a CSV file
Antagonists | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific antagonist tables |
Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
CD36 expressed by macrophages plays a key role in the recognition and phagocytosis (scavenging) of multiple ligands that are recognised either as damage-associated molecular patterns (DAMPs) released by apoptotic cells, or as potentially dangerous pathogen-associated ligands. CD36 associates with specific Toll-like receptor (TLR) DAMP-detecting heterodimers when bound by certain ligands, and following internalisation of the ligand/CD36/TLR clusters, inflammatory responses (e.g. NF-κB-dependent production of CXCL1, CXCL2, CCL9 and CCL5, NLRP3 inflammasome-mediated IL-1B production, and NF-κB-dependent production of TNF in reponse to microbial diacylated lipopeptide) are triggered. Pharmacological modulation of CD36/TLR signalling is being explored as a strategy to suppress macrophage-driven inflammation [1,5-6]. To date research has focussed on the development of azapeptide and azasulfurylpeptide ligand mimetics, which are designed with minimal liability with regards to neovascularization and with optimised and selective activity towards the CD36-mediated TLR2/6-triggered innate inflammatory response (i.e. pro-inflammatory cytokine and chemokine production in macrophages). |
Cell Type Associations | ||||
|
Physiological Functions ![]() |
||||||||
|
Physiological Consequences of Altering Gene Expression ![]() |
||||||||||
|
1. Danelius E, Ohm RG, Ahsanullah, Mulumba M, Ong H, Chemtob S, Erdelyi M, Lubell WD. (2019) Dynamic Chirality in the Mechanism of Action of Allosteric CD36 Modulators of Macrophage-Driven Inflammation. J Med Chem, 62 (24): 11071-11079. [PMID:31774287]
2. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest, 105 (8): 1049-56. [PMID:10772649]
3. Proulx C, Picard É, Boeglin D, Pohankova P, Chemtob S, Ong H, Lubell WD. (2012) Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a. J Med Chem, 55 (14): 6502-11. [PMID:22712585]
4. Souza AC, Bocharov AV, Baranova IN, Vishnyakova TG, Huang YG, Wilkins KJ, Hu X, Street JM, Alvarez-Prats A, Mullick AE et al.. (2016) Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int, 89 (4): 809-22. [PMID:26994575]
5. Turcotte S, Mellal K, Chingle R, Mulumba M, Omri S, Dif-Yaiche L, Chemtob S, Ong H, Lubell WD. (2018) Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization. Biomedicines, 6 (4). [PMID:30360354]
6. Zhang J, Mulumba M, Ong H, Lubell WD. (2017) Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics. Angew Chem Int Ed Engl, 56 (22): 6284-6288. [PMID:28090719]
CD molecules: CD36 molecule (CD36 blood group). Last modified on 25/03/2024. Accessed on 25/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=3104.